Michigan Life Sciences Showcase

REGISTRATION IS NOW OPEN!

The Showcase brings together industry professionals, thought leaders, and changemakers from all Life Sciences sectors with patients and patient advocates, higher education and research professionals, services providers, students, and economic development and non-profit partners to promote industry connectivity, share best practices, and emerging trends insights, explore the changing healthcare landscape, and drive industry growth.

This event includes five MichBio’s signature events – Drug Discovery Symposium, Medical Device Summit, Digital Health Forum, Cannabis Science Symposium, and Patient Advocacy Forum – with dedicated tracks for each event, as well as an exhibit floor featuring suppliers and vendors serving the life sciences, research and technology presentations, and networking opportunities.

XLerateHealth’s Flagship Accelerator Bootcamp is now accepting applications for the 10th edition! If you’re a healthcare, bio-tech, or clinician founder looking to accelerate the development of your technology and bring it to market, apply now! 

The deadline for applications is June 2nd, and virtual sessions will run from July 7th to September 30th. 

XLerateHealth, a nationally renowned healthcare accelerator, is seeking early-stage companies and entrepreneurs who are addressing pain points in the healthcare industry. With a wealth of national collaborators, the XLerateHealth team has a unique depth of knowledge in successfully developing healthcare and life science startups. XLH focuses on helping early-stage healthcare companies validate their business model, build out their commercialization strategy, and get ready to attract funding. 

NEW R&D Tax Credit Offering for Members

ADP MEMBER BENEFIT

ADP is already providing MichBio members with HR and total employment solutions. Now, we are enhancing the partnership with a new R&D tax credit offering for MichBio members.

Are you claiming your R&D tax credit expenses? Unsure of what activities qualify? Reach out today for a free initial assessment performed by ADP tax professionals. If they find eligible expenses, they will guide you through the entire R&D tax credit process at a discounted rate. Get your free initial assessment today.

UPS Healthcare: Exact Science Case Study

MICHBIO MEMBER BENEFIT

When Exact Sciences created a revolutionary way to screen for colorectal cancer at home, they turned to UPS to handle the delivery of tests and the swift return of specimens.

What can UPS Healthcare do for you?

Visit michbio.org/membership/ for a full list of MichBio member benefits.

BIO and BBC Storyworks Partner for Second Video Series

NATURE'S BUILDING BLOCKS

Featuring world-first innovations and cutting-edge developments from recent years, this series is a showcase of what science can achieve, brought to life through beautiful, compelling, and often deeply personal stories of the people responsible for dramatic progress – and those who stand to benefit.

In Nature Positive, discover emerging and established biotech-based solutions that help to tackle the climate crisis. In Building Health you’ll learn about the technologies defining the present and future of medicine. Stopping the Blocks is a powerful set of stories about making therapies accessible to those previously missing from the conversation.

MICHBIO & MIDEVICE MEMBERS FREE*

Networking Mixer

May 24 - 5:00 to 7:00 pm - Grand Rapids, MI

MichBio and MiDevice are partnering to bring a networking event to Grand Rapids.

Life Sciences industry and academic professionals, students, and enthusiasts are invited to Thornapple Brewing for casual conversation and relationship building.

Drinks and Appetizers provided.

*MiDevice members contact alisha@michbio.org or elliotj@rightplace.org for coupon code.

Midwest Growth Capital Symposium

May 23&24 - Ann Arbor

This year the MGCS will feature up to 60 pre-selected Midwest companies seeking seed, series-A, and series-B funding that span the Life Sciences, Healthcare, Tech, Food & Agriculture, and Energy sectors. Additionally, the Big 10’s Tech Transfer Pitch Track will highlight 15-20 companies. Attendees will have the chance to connect with early-stage companies, angel investors, venture capitalists, technology transfer professionals, and leading entrepreneurs from the Midwest and beyond. Stay connected, find resources, and see what keeps attendees coming back – in person or online – year after year! 

RESI Conference

June 5-7 - Boston, MI

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development.

BIO International Convention

June 5-8 - Boston, MA

Stand up for innovation. Stand up for truth. And stand up for science. It’s time to inspire, honor, and recognize the true value of the breakthrough work biotech performs for society. Today. And every day. Well into the future. 

It’s never been more important to stand up for science, for biotech, for innovation. Join us June 5-8, 2003, in Boston for four days to explore the hottest industry topics, a vibrant exhibit floor, networking, BIO One-on-One Partnering^TM, and much more.

REGISTRATION NOW OPEN!

Michigan Life Sciences Showcase

Sept. 18 - Lansing, MI

The Showcase brings together industry professionals, thought leaders, and changemakers from all Life Sciences sectors with patients and patient advocates, higher education and research professionals, services providers, students, and economic development and non-profit partners to promote industry connectivity, share best practices and emerging trends insights, explore the changing healthcare landscape, and drive industry growth.

This event includes five MichBio’s signature events – Drug Discovery Symposium, Medical Device Summit, Digital Health Forum, Cannabis Science Symposium, and Patient Advocacy Forum – with dedicated tracks for each event, as well as an exhibit floor featuring suppliers and vendors serving the life sciences, research and technology presentations, and networking opportunities.

BIO Impact Ag & Environment Conference

September 19-20 - Raleigh, NC

The BIO Impact Ag & Environment Conference is centered on overcoming today's global challenges - and set forth towards a more sustainable future - by embracing the key role biotechnology plays in protecting our planet's resources, driving a strong economy, and improving people's lives. 

• New Traceable Opioid Material® Kit Expands Coverage to Other Emerging Drugs of Concern in Seized Samples and Toxicological Casework
• AdvaMed Responds to Proposed Rules Governing Ethylene Oxide’s Role in Sterilizing Medtech
• New I Am BIO Podcast: The New Age of CRISPR
• Report sees booming orphan drug market threatened by price controls
• MichBio & BIO join amicus brief against mifepristone ruling
• Opinion Piece: Medical Device Sterilization is Critical for Patient Safety
• National Cancer Plan Released: Read the Full Plan
• Increasing Threat of Spread of Antimicrobial-resistant Fungus in Healthcare Facilities
• IP waiver directly threatens U.S. medical innovation, biomanufacturing
• MMS Scientific Advisory Board’s New Members Expand CRO’s Therapeutic Expertise
• As the COVID pandemic turns 3, are we ready for the next one?
• Canada requests Mexico talks on GMO ban after U.S. corn move
• The Future of Sustainable Pork
• Will gene therapies for ultra-rare diseases become a cautionary tale – or life-saving products?
• Paving the way for the world's first RSV vaccine, FDA advisers recommend two different shots
• ‘All hands on deck’ needed to address U.S. pain and addiction innovation
• REPORT: The State of Innovation in Pain and Addiction
• Increase in Extensively Drug-Resistant Shigellosis in the United States
• Moderna and Merck investigational personalized mRNA cancer vaccine, in combination with Keytruda, granted breakthrough therapy designation by FDA
• Biosimilars expected to boom in 2023-27, says report
• Food and Agricultural Climate Alliance Release Farm Bill Recommendations
• BIO’s long COVID webinar furthers search for biotech solutions
• MMS Partners with I-ACT to Advance Children’s Clinical Trials

MichBio Members: Do you have news you would like included in the next newsletter? Submit it to alisha@michbio.org.

Federal

Grave Concerns Resulting from Court Decision to Suspend Abortion Pill Approval and Access

MichBio, like many other stakeholders in the life sciences industry, has serious concerns over the recent Texas Court decision to suspend the FDA approval of abortion pill mifepristone and what it may mean more broadly for the FDA’s ability to regulate drug reviews and approval. The decision, should it stand upon appeal, would set a very dangerous precedent. Read more.

MichBio Visits Capitol Hill 2X

Spring in Washington, DC annually witnesses the ritual of Legislative Fly-Ins whereby many special interest groups descend on Capitol Hill to advocate their policy priorities. This year was no different, except for the fact that it was the first time such pilgrimages were made in three years due to the pandemic. Read more.

Legislative Fly-In Participant Perspectives

Gene Parunak of in2being, LLC

"This was my second time trying to keep up with MichBio's Stephen Rapundalo as we literally and figuratively navigated the labyrinth that is Capitol Hill. It was an honor to be part of the MichBio delegation to the AdvaMed annual legislative fly in for medical devices on March 7th and 8th, 2023. As a lifelong techie and a politically agnostic person, I've rarely had interest in the "swamp" of DC, but on my first trip with MichBio in 2016, I learned that the conversations on the hill (away from the news cameras, which seem to act as divisive lenses) is actually thoughtful, nuanced, civil, and dare I say, human....

As in 2016, I was impressed by the engagement of the congressional staffers and their knowledge of the issues. They are also uniformly passionate about hearing from their constituents. The last time I was on the hill with MichBio, the issue of the day was the medical device excise tax, an ill-conceived effort that penalized pre-profit startup companies. Fortunately, that has since been repealed." Read more.

Laura Bonnell of The Bonnell Foundation: Living with Cystic Fibrosis

"I was reminded of how important it is for legislators and aides to hear the patient's voice. I encourage everyone to tell their story in Washington, D.C. They are listening. You can literally be at the table and be part of the change you hope to see."

Repeal of R&D Amortization

The America Innovation and R&D Competitiveness Act of 2023 was reintroduced that would repeal current rules and allow a business to deduct of R&D costs in the tax year that they occur and thereby incentivize long-term investments in innovation. Read more.

EPA to Limit Ethylene Oxide Emissions from Medical Device Sterilizers

Medical device sterilizers will face new limits on ethylene oxide (EtO) emissions and new requirements for worker protection, according to a pair of proposals issued by the EPA. The new limits are part of a broader series of actions by the agency to reduce exposure to the chemical, which it said can increase cancer risks over the course of a career or a lifetime. Companies will have 18 months to install the required pollution controls after the EPA issues a final rule. Read more.

Senate Takes Up Drug Pricing Legislation

The Senate HELP Committee is taking up four bills – S 1607 (Ensuring Timely Access to Generics Act of 2023), S 1214 (Retaining Access and Restoring Exclusivity Act of 2023), S 1114 (Expanding Access to Low-Cost Generics Act of 2023), and S 1339 (Pharmacy Benefit Manager Reform Act) – introduced with a focus on regulating drug prices in one way or another. The Committee has planned a “markup” wherein amendments to the introduced legislation will be considered and voted on. 

MADE in America Act Reintroduced

Reps. Buddy Carter (R-GA) and Carol Miller (R-WV) reintroduced the Manufacturing API, Drugs, and Excipients (MADE) In America Act to prevent U.S. pharmaceutical supply chain dependence on China and other foreign adversaries. The MADE in America Act will stimulate domestic manufacturing of drugs and pharmaceutical supplies such as active pharmaceutical ingredients (API) and personal protective equipment (PPE) while reducing drug shortages. 

Bills To Help Early-Stage Innovators Access Working Capital

The House Financial Services Committee, in a marathon session late April, considered a package of 15 bills designed to relieve regulatory burdens and facilitate access to needed capital for biotech startups. Read more.

State

Rare Disease Advisory Council – Take 2

Rep. Jason Morgan (D- MI-23) introduced HB 4167 late February, the latest attempt to establish a Rare Disease Advisory Council (RDAC) in Michigan. A RDAC would empower rare disease patients as partners in helping to shape policy development relevant to the unmet needs, common struggles, and concerns on equitable, quality, and affordable access to specialty treatment. Read more.

Drug Price Transparency Bill Introduced

HB 4409, the “Drug Manufacturer Data Reporting Act” was introduced recently by Rep. Steckloff (D-MI-19), as an attempt to seek more transparency and control of drug prices. The bill would require biotech/pharma companies to provide information on a range of expenses including R&D, marketing, clinical development, whether and how much the company received in federal funds to support a drug’s development, and more. Read more.

Michigan Life Science Organizations Are Hiring

OPEN POSITIONS

Ann Arbor

• Specialist II Standards
• Technician II DWTS 

Lansing

• Services Operations Specialist - Detroit Metro Area

Grand Rapids

• Manufacturing Specialist
• Continuous Improvement Leader
• Manager of Asset Reliability Tablet Packaging
• Manufacturing Engineer

Novi

• Senior Scientist

Riverview

• Chemical Operator

Beaverton

• Manufacturing Designer II - Life Sciences

Mattawan

• PK Research Scientist 2 - Remote
• Clinical Pathologist II

Livonia

• Director of Pharmaceutical Industry Solutions

International Filtration Services is a filtration manufacturer and distributor for MRO filtration materials and services for automotive, healthcare, pharma, industrial, and commercial customers (B2B).

The company's mission is to deliver world class services and filtration products for end users clean air and liquid needs.

International Filtration Services is located in Belleville, MI.

• International Filtration Services
• Nipuna Therapeutics

• Sublime

• COPD Foundation
• DeHydr8 LLC
• in2being, LLC
• Intra-Cellular Therapies
• Keystone Solutions Group
• Lawrence Technological University Biomedical Engineering and Natural Sciences Department
• MDRS, LLC
• Michigan Center for Medical Research
• Michigan Ovarian Cancer Alliance
• Multiple Sclerosis Association of America
• Nancerox

• NeuMoDx Molecular, Inc
• Northern Biomedical Research
• Oxford Biomedical Research
• Packaging Compliance Labs
• PharmaForensics Laboratories
• PSI Labs
• Quality Systems Compliance
• Spartan Innovations
• Strata Oncology
• Tetra Therapeutics
• The Bonnell Foundation: Living with Cystic Fibrosis
• The Spott